Rose Sekulovich

Years Active: 2022-2022
Publications (10 Years): 3

This page only lists publications with an associated author ORCID identifier.

Publications

Jenny Guek-Hong Low, Ruklanthi de Alwis, Shiwei Chen, Shirin Kalimuddin, Yan Shan Leong, Tania Ken Lin Mah, Natalene Yuen, Hwee Cheng Tan, Summer L Zhang, Jean X Y Sim, Yvonne F Z Chan, Ayesa Syenina, Jia Xin Yee, Eugenia Z Ong, Rose Sekulovich, Brian B Sullivan, Kelly Lindert, Sean M Sullivan, Pad Chivukula, Steven G Hughes, Eng-Eong Ooi
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine. NPJ vaccines 7 (1) (2022)
Jenny Guek-Hong Low, Ruklanthi de Alwis, Shiwei Chen, Shirin Kalimuddin, Yan Shan Leong, Tania Ken Lin Mah, Natalene Yuen, Hwee Cheng Tan, Summer L Zhang, Jean X Y Sim, Yvonne F Z Chan, Ayesa Syenina, Jia Xin Yee, Eugenia Z Ong, Rose Sekulovich, Brian B Sullivan, Kelly Lindert, Sean M Sullivan, Pad Chivukula, Steven G Hughes, Eng-Eong Ooi
A phase I/II randomized, double-blinded, placebo-controlled trial of a self-amplifying Covid-19 mRNA vaccine. NPJ vaccines 7 (1) (2022)
Eugenia Z Ong, Jia Xin Yee, Justin Seng Geap Ooi, Ayesa Syenina, Ruklanthi de Alwis, Shiwei Chen, Jean X Y Sim, Shirin Kalimuddin, Yan Shan Leong, Yvonne F Z Chan, Rose Sekulovich, Brian B Sullivan, Kelly Lindert, Sean B Sullivan, Pad Chivukula, Steven G Hughes, Jenny Guek-Hong Low, Eng-Eong Ooi, Kuan Rong Chan
Immune gene expression analysis indicates the potential of a self-amplifying Covid-19 mRNA vaccine. NPJ vaccines 7 (1) (2022)

Rose Sekulovich.css-eqlu8i{font-size:small;padding-left:4px;}